ICRP’s Radon Initiative
Transcript of ICRP’s Radon Initiative
ICRP’s Radon Initiative
Presented To:
National Mining Association (NMA)
/Nuclear Regulatory Commission (NRC)
Uranium Recovery Workshop Denver – June 18 & 19, 2014
Presented By:
Douglas B. Chambers, Ph.D
1
International Radiation Safety Regime
issues
levels
trends
ICRP Protection philosophy,
principles and units issues
effects
risks
ILO convention 115:
occupational
radiation protection
FAO/WHO
Codex Alimentarius Commission
(food contamination guides)
UN transport regulations for
radioactive material
implemented by
Member States
IAEA, WHO, ILO, FAO etc. -Safety standards
-Protection programmes
UNSCEAR
Scientific basis
recommendations
2
ICRP and Radon
1993 - ICRP Publication 65 Protection against radon-222 at
home and at work ( based on epidemiology).
2009 - Porto Statement
The ICRP issued a statement on radon which stated that the dose
conversion factor for radon progeny would likely double, and the calculation
of risk from radon should move to a dosimetric approach, rather than the
longstanding epidemiological approach.
The ICRP approved the formation of a new Task Group, reporting to
Committee 4, to develop guidance on radiological protection against radon
exposure.
2011 - ICRP PUBLICATION 115 — Lung Cancer Risk from
Radon and Progeny and Statement on Radon
20014 - Coming soon from C4- Radiological Protection against
Radon Exposure
3
ICRP’s New Approach
Currently ICRP uses a dose conversion convention
(DCC) to calculate effective dose per unit exposure to
radon progeny based on epidemiology.
The detriment adjusted risk coefficient for radon will
double.
Doses from radon and its progeny will be calculated
using ICRP biokinetic and dosimetric models.
Current dose conversion values may continue to be
used until new ICRP dose coefficients are available.
4
Epidemiology – a few comments
Currently based on relative risk models
Relative risk models depend on baseline
risk
Smoking is the major cause of lung cancer
Smoking prevalence is an important factor
in baseline lung cancer rates
5
Ratio of Risks of Age-specific Deaths
in Male Smokers/Non-Smokers
0
5
10
15
20
25
30
35
40
45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+
Dea
ths
per
10
0,0
00
pers
on
-ye
ars
Age Group
Lung
All causes
Lung Cancer Mortality of Smokers vs.
Non-smokers
Overall Mortality of
Smokers vs. Non-smokers
Thun et al. (1997)
Age-Specific
Deaths
6
Smoking Prevalence (Country)
7
15
20
25
30
35
40
45
45
50
55
60
65
70
75
80
85
1979 1984 1989 1994 1999 2004 2009 2014
Pe
rce
nta
ge (
%)
Mo
rtali
ty R
ate
, C
as
es
per
10
0,0
00
Year
Lung Cancer Smoking Prevalence
Age-Standardized Mortality Rates and Smoking
Prevalence for Lung Cancer in Males, Canada 1983-2012
• Canadian Cancer Society Statistics (2012)
• Tobacco Use in Canada: Patterns and Trends , 2012 Edition
8
Epidemiological Results
Risk projection models are relative risk models
and characteristics of underlying populations
are important
Smoking is the dominant risk for lung cancer
ICRP 115 report notes risk is on the order of 20 times
greater for smokers vs. non-smokers
General trend of declining smoking rates
9
Key Environmental Factors
Total alpha activity.
Particle activity size distribution in the mine
atmosphere.
Fraction of unattached radon decay products.
10
Past Measurements
The major factor controlling the bronchial dose from
inhalation of 222Rn decay products is their associated
particle size (activity size distribution).
The decay products attach mainly to the ambient
particle distribution but a small fraction, mainly 218Po,
remain as small nuclei called the unattached fraction.
Activity size distributions in mines have not been well
measured, mainly because it is a difficult research area
and the instruments are mainly for laboratory use.
11
Experimental Setup
Saskatchewan Mine (Nov 1995) Keng Wu-Tu, Isabel M. Fisenne and Adam R. Hutter (EML 1997)
12
The attached radon progeny are associated with the accumulation
mode aerosol with activity median thermodynamic diameters
(AMTD) of 50 - 500 nm.
Diffusion batteries utilising tubes, parallel plates, porous carbon
or wire screens have all been used to measure radon daughter
activity size distributions in this size range.
Measurement of Activity
Size Distribution
Source: Solomon, July 2011
13
Behaviour of DCF with particle size is strongly affected by two sets of deposition processes following inhalation:
With size decreasing below 3 nm there is a dose reduction due to deposition losses in the nose;
Above 20 nm the dose decreases due to increased penetration into the lower respiratory tract.
Can match to DCF size behaviour using two wire screens, one for nasal deposition, the other respiratory tract collection.
“Effective Dosimeter” reads out directly in mSv/h.
ARPANSA “Effective Dosimeter”
Source: Solomon, July 2011
14
Aerosol Size Distribution
Radon daughter PAEC
particle size distribution
measured by ARPANSA
with combined 4-stage
serial graded screen array
and 5-stage parallel
screen diffusion battery in
an Australian diesel
operated underground
uranium mine
Olympic Dam).
Source: Solomon, July 2011 (based on 1995 study)
15
Field Sampling Requirements The need for, easily deployable, and relatively portable
instrumentation.
The need for small, robust, reliable flow controllers for the
sampler.
The need for continuous flow measuring equipment for the
sampling instrument.
The need for low background, high efficiency alpha counting
equipment for the measurement.
The need for a reliable deconvolution program for data
reduction that records the error for the derived size
distributions.
The need for size distribution validation, i.e., quality control,
for the sampling equipment. Inter comparison exercises are
important.
16
Available Instrumentation
for Particle Size Measurements Cascade Impactors: rely on change on air velocity directed
through sequential plates.
Mobility Analyzers: depend upon differing electrical mobility
for particle size separation.
Graded Screen Arrays: Graded screen arrays (GSA) use the
same air flow rate through screens of different mesh size, usually
60 to 600mesh. The size separation is based on differing diffusion
coefficients with diameter.
Multi element: e.g., NYU (Harley’s) IMP with an inlet impactor,
that collects on a ZnS disk for direct counting, followed by 4 fine
mesh screens (GSA) and an exit Millipore backup filter to capture
all residual particles
17
Measurement Issues
Variability (mine to mine, within mine, change with
time).
Technical feasibility (e.g. instrumentation).
Operational (level of effort, suitable locations,
frequency).
Administrative (incorporate into dose estimation
protocol, national dose registry based on
measurement of WLM and estimates of WLM).
Interpretability/consistency for compliance with
national regulation.
18
Measurement Protocol
No “standard” protocol is currently available
A protocol is needed to ensure comparability
and interpretability of results across mines and
countries
Protocol needs to consider variability of mine
atmosphere
19
Dosimetric Models
20
ICRP’s 66 HRTM, will be the basis for
radon progeny conversion factors
Radiation dose from inhaled radon
progeny depends on deposition site
within the respiratory tract
Lung cancer from RDP is associated
with radiation exposure to the
bronchial region of the lung
This is dependent on the size of the
radon progeny particles
Estimated doses depend on the
physical model and numerous
assumptions
ICRP66 Human Respiratory
Tract Model
21
Dose Modelling
Dose modelling has been performed for the
selected ranges of environmental parameters.
The dose modelling has been performed by UK
HPA using the HPA’s implementation of the
ICRP’s HRTM model.
22
Monodisperse aerosol (i.e. GSD = 1.0)
with unit density (ρ) and shape factor (χ),
HPA (August, 2012)
0.00
20.00
40.00
60.00
80.00
100.00
120.00
140.00
0.1 1 10 100 1000 10000
Do
se
( m
Sv p
er
WL
M)
Particle size (nm)
Effective and tissue weighted lung dose
Tissue weighted lung dose
Effective dose
Series3
10 mSv/WLM
23
Effective Dose
Absorbed dose to relevant tissue (model and
assumption dependent)
Alpha radiation weighting factor (wR)
[20 default, 10 lung cancer]
Tissue weighting factor (wT) [nominal
averaged over age and sex; and smoking
characteristics of ICRP 103 populations
[lung (0.12) and bronchial (0.08)]
24
Dosimetry and Smoking
The current ICRP dosimetry model (HTRM, ICRP 66)
indirectly considered smoking through wT,
A recent paper by Baias, et al. (2010) has calculated
dose conversion factors (mSv/WLM) for four different
categories of smokers taking account of the thickening of the mucus layer ( 2 fold decrease in dose factor)
impaired mucociliary clearance (a 2 fold increase in dose factor)
Calculations of Baias et al. partly account for physical
effects of smoking but epidemiology suggests a much
larger (10 fold) range of risks than those reported by
Baias et.al Biology considerations are important
25
Radon Dose Conversion Ranges 25
20
15
10
5
0
DC
C (
mS
v/W
LM
)
Occupational
Public
Occupational
Public (BEIR VI)
(French/Czech)
(ICRP 65)
Tomasek
-Occupational
(2008)
Epidemiology
ICRP
(11/07/2010)
ICRP 65
(1993)
LEGEND:
Heavy Long-Term Smoker
Never Smoker
Heavy Short-Term Smoker
HLT
NS
HST 21
(50% Smoker)
1 (Non-Smoker)
6-7 (Median)
Effect of Smoking
Epidemiology
SENES (2011)
21.1 Home
20.9 Mine
(Tomasek et al 2004)
6.4 Indoor
(ICRP 50)
Dosimetry
Table B.1
ICRP 115 (2010)
13.34 HLT
1.74 HST (2)
Dosimetry
Baias et al
(2010)
7.2 NS
26
Some of the Issues in Mines
All miner epi studies to date have used WLM as measure
of exposure
WL and WLM are common metric world-wide
There are well established protocols for measuring
“dose” by WLM
Uranium miners are well monitored and assigned
exposures in WLM
Modern exposures are low
The WLM is well recognized as a factor representing the
“notional” risk of lung cancer and current regulations
are based on meeting WLM limits
27
Some of the Challenges
Very Limited relevant data on mine aerosols
Currently technical and operational challenges for
making measurements in mines
Mine environment conditions are variable (mine to
mine, within mine, change with time) – challenge to
interpret mine levels to exposure
No measurement protocol currently exists
A possible wide range on Dose Conversion Factors
represents challenges for interpretability/consistency
for compliance with national regulation
etc.,
28
Questions ?
29